Dermata Therapeutics, Inc.
DRMA
$1.27
$0.010.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.35% | 8.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.93% | -0.68% | |||
| Operating Income | -7.93% | 0.68% | |||
| Income Before Tax | -10.04% | 0.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.04% | 0.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.04% | 0.53% | |||
| EBIT | -7.93% | 0.68% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.11% | 38.20% | |||
| Normalized Basic EPS | 0.11% | 38.20% | |||
| EPS Diluted | 0.11% | 38.20% | |||
| Normalized Diluted EPS | 0.11% | 38.20% | |||
| Average Basic Shares Outstanding | 10.15% | 60.94% | |||
| Average Diluted Shares Outstanding | 10.15% | 60.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||